US Patent 11091521 Immunogenic compositions comprising
Patent 11091521 was granted and assigned to Infectious Disease Research Institute on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+326 characters)
Article
Patent abstract
The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gregory C. Ireton0
Rhea N. Coler0
Steven G. Reed0
Sylvie Bertholet0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110915210
Date of Patent
August 17, 2021
0Patent Application Number
201711160
Date Filed
November 16, 2017
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11091521 Immunogenic compositions comprising
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11091521
Date of patent
August 17, 2021
Patent application number
20171116
Date Filed
November 16, 2017
Find more entities like US Patent 11091521 Immunogenic compositions comprising
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.